Pioglitazone Hydrochloride
- Product NDC
- 71335-2027
- 11-digit product format
- 713352027
- Labeler code
- 71335
- Product ID
- 71335-2027_225a1f8a-d516-4548-996b-b5296dc6dbc2
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Pioglitazone Hydrochloride
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA076798
- Marketing category
- ANDA
- Marketing start
- 2020-10-28
- Marketing end
- 0000-00-00
- Substance
- PIOGLITAZONE HYDROCHLORIDE
- Active strength
- 15 mg/1
- Pharmacologic classes
- PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 71335-2027-1 | 71335202701 | 30 TABLET in 1 BOTTLE (71335-2027-1) | 30 tablet | 2022-02-24 | 0000-00-00 | No | No | Current |
| 71335-2027-2 | 71335202702 | 90 TABLET in 1 BOTTLE (71335-2027-2) | 90 tablet | 2022-02-24 | 0000-00-00 | No | No | Current |
| 71335-2027-3 | 71335202703 | 60 TABLET in 1 BOTTLE (71335-2027-3) | 60 tablet | 2022-02-24 | 0000-00-00 | No | No | Current |
| 71335-2027-4 | 71335202704 | 120 TABLET in 1 BOTTLE (71335-2027-4) | 120 tablet | 2022-02-24 | 0000-00-00 | No | No | Current |